Home > Healthcare > Medical Devices > Diagnostic Devices > Fractional Flow Reserve Market

Fractional Flow Reserve Market Size, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2024 – 2032

  • Report ID: GMI3627

Fractional Flow Reserve Market Size

Fractional Flow Reserve (FFR) Market size is expected to grow at a significant rate between 2024 and 2032, driven by the increasing incidences of cardiovascular diseases.

As per WHO, cardiovascular diseases (CVDs) stand as the primary cause of death, claiming approximately 17.9 million lives annually across the globe. According to the Centers for Disease Control and Prevention (CDC), heart-related diseases are the primary cause of death in people belonging to various racial or ethnic groups in the U.S. Around 805,000 Americans get a heart attack annually of which 605,000 are first-time heart attacks and 200,000 heart attacks occur in those who have already experienced one.

With surge in CVD prevalence, there is a higher demand for accurate diagnostic tools like FFR to assess coronary artery disease severity and guide treatment decisions. The growing awareness among healthcare professionals about the clinical benefits of FFR in optimizing coronary interventions and improving patient outcomes is driving its adoption. Moreover, favorable reimbursement policies and government initiatives aimed at reducing healthcare costs and improving patient care quality.

Fractional Flow Reserve Market Trends 

One notable trend is the advancements in FFR technologies, including wireless and pressure-wire-free systems, which improve usability and precision. Also, the developments in imaging and catheterization techniques, have improved the accuracy and reliability of FFR measurements, making it a preferred choice for clinicians. The ongoing R&D efforts aimed at refining FFR techniques and expanding their applications will further shape the industry outlook in the coming years.

Fractional Flow Reserve Market Analysis

Based on product, the guidewires segment is expected to hold a major market share during 2024-2032 as the instrument vastly helps cardiologists in determining the severity of cardiovascular disease in patients. They also help in the effortless positioning of catheters that aid patients better manage their condition. Since the guidewires are small, they can easily pass through the arteries, thereby escalating their use among surgeons.

Based on application, the single-cell coronary artery disease (CAD) segment is anticipated to generate notable revenues by 2032, attributed to lifestyles changes and eating habits of the population. The sedentary lifestyle and excessive consumption of fast and pre-cooked foods are on the rise because of people's erratic schedules. Excessive consumption of junk foods and lack of physical activity leads to artery blockages, bolstering the product adoption.

North America fractional flow reserve market is set to witness a sustained growth over 2024 and 2032, attributed to the region’s geriatric population. As per CDC, hypertension, smoking, and high blood cholesterol are the primary factors contributing to the rise in cardiac diseases. The rapid progression in fast-food chains and the processed foods sector attracts consumers towards pre-cooked foods, which will accelerate the risks of CAD, thereby propelling regional industry expansion.

Fractional Flow Reserve Market Share

Some of the renowned companies functional in the fractional flow reserve industry are:

  • CathWorks
  • ACIST Medical Systems
  • Abbott Laboratories
  • Pie Medical Imaging
  • Opsens Medical
  • Boston Scientific Corporation
  • Koninklijke Philips N.V.
  • Siemens Healthcare

Fractional Flow Reserve Industry News

  • In April 2023, Lumina Imaging, a network of imaging centers focused on consumer needs, and Siemens Healthineers, a renowned global medical technology leader, have established a long-term strategic collaboration aimed at expanding outpatient imaging.
  • In February 2024, Cleerly announced that its Cleerly ISCHEMIA software, recently FDA-cleared, can now be billed under CPT® code 75580 when used with a non-invasive CCTA. This service, defined by the AMA, serves as a complementary tool providing noninvasive FFR estimates to assist healthcare professionals in clinical diagnosis.

What Information does this report contain?

Historical data coverage: 2018 to 2023; Growth Projections: 2024 to 2032.
Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts: major segments covering applications, top products and geographies.
Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.
Authors: Mariam Faizullabhoy

Pre Book Now